Insight in the prediction of chemotherapy-induced nausea.

Purpose: To identify risk factors for chemotherapy-related nausea.

Methods: We examined risk factors for nausea in 1,696 patients from three multicenter studies conducted from 1998 to 2004. All patients were beginning a chemotherapy regimen containing cisplatin, carboplatin, or doxorubicin.